Ciclosporin in Rheumatoid Arthritis: Open Trials with Different Dosages

  • B. Amor
  • M. Dougados

Abstract

We report on our experience of two pilot studies of ciclosporin (CyA) in the treatment of rheumatoid arthritis (RA), a disease in which functional T cell abnormalities have been clearly demonstrated [2].

Keywords

Fatigue Toxicity Arthritis Creatinine Corticosteroid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lee P, Jasani MK, Dick NC, Buchanan WW (1973) Evaluation of a functional index in rheumatoid arthritis. Scan J Rheumatol 2:71–77CrossRefGoogle Scholar
  2. 2.
    NIH Conference; Moderator: Decker JL (1984) Rheumatoid arthritis: evolving concepts or pathogenesis and treatment. Ann Intern Med 101:810–824Google Scholar
  3. 3.
    Palestine AG, Nussenblatt RB, Chanc C (1984) Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 77:652–656PubMedCrossRefGoogle Scholar
  4. 4.
    Powles RL, Clinck HM, Spence D, et al. (1980) Cyclosporin A to prevent graft-versus host disease in man after allogeneic bone marrow transplantation. Lancet I:327–329CrossRefGoogle Scholar
  5. 5.
    Ritchie DM, Boyle JA, Mc Ines JM, Grieveson P, Buchanan NN (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. J Med 7:393–406Google Scholar
  6. 6.
    Starzl TE, Iwatsuki S, Bahnson HB (1982) Cyclosporin A and steroids for liver and heart transplantation. In: White DJG (ed) Cyclosporine A. Elsevier Biomedical Press, Amsterdam, p 431–436Google Scholar

Copyright information

© Sandoz Ltd, Basle 1985

Authors and Affiliations

  • B. Amor
    • 1
  • M. Dougados
    • 1
  1. 1.Department of Rheumatology, Prof. B. AmorHôpital CochinParisFrance

Personalised recommendations